STADA Arzneimittel AG (SAZ)
STADA Arzneimittel AG is engaged in the provision of healthcare and pharmaceutical products. It operates through Generics and Branded Products segments. The Generics segment produces and distributes generic drugs. The Branded Products segment sells branded healthcare products and medicines. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany.
|Market Price at 08-12-2017||80,80 €|
|Price to Earnings Ratio||17,26|
|Market Capitalisation||5.037,07 € (million)|
|Return on Equity (ROE)||18,31%|